Metacrine To Go Ex-Dividend On June 21st, 2023 With 0.58 USD Dividend Per Share
June 20th - $Metacrine(MTCR.US)$ is trading ex-dividend on June 21st, 2023. Shareholders of record on June 15th, 2023 will receive 0.58 USD dividend per share on June 20th, 2023. The ex-dividend d
Tudor Investment Corp Et Al Makes New $169,000 Investment in Metacrine, Inc. (NASDAQ:MTCR)
Tudor Investment Corp Et Al bought a new stake in Metacrine, Inc. (NASDAQ:MTCR – Get Rating) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersHTG Molecular Diagnostics (NASDAQ:HTGM) shares moved upwards by 33.0% to $6.01 during Wednesday's after-market session. This security traded at a volume of 323.6K shares come close, making up 2
Insider Selling: Metacrine, Inc. (NASDAQ:MTCR) CEO Sells $156,048.05 in Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) CEO Preston Klassen sold 380,605 shares of the company's stock in a transaction that occurred on Thursday, January 26th. The stock was sold at an average pr
Preston Klassen Sells 380,605 Shares of Metacrine, Inc. (NASDAQ:MTCR) Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) CEO Preston Klassen sold 380,605 shares of the firm's stock in a transaction on Thursday, January 26th. The stock was sold at an average price of $0.41, for
Insider Selling: Metacrine, Inc. (NASDAQ:MTCR) Insider Sells 107,054 Shares of Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) insider Michael York sold 107,054 shares of Metacrine stock in a transaction on Thursday, January 26th. The stock was sold at an average price of $0.41, for
Insider Sell: Metacrine
04:46 PM EST, 01/27/2023 (MT Newswires) -- Preston Klassen, Director, President and CEO, on January 26, 2023, sold 380,605 shares in Metacrine (MTCR) for $157,266. Following the Form 4 filing with the
Metacrine, Inc. (NASDAQ:MTCR) Sees Significant Decrease in Short Interest
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 87,400 shares, a decrease
Metacrine (NASDAQ:MTCR) Shares Up 9.5%
Metacrine, Inc. (NASDAQ:MTCR – Get Rating)'s share price shot up 9.5% on Wednesday . The company traded as high as $0.50 and last traded at $0.48. 1,115,206 shares were traded during trading, an inc
Metacrine Says President, CEO, Secretary, Principal Executive Officer Preston Klassen Was Terminated From Positions, Effective Feb. 1
Metacrine Says President, CEO, Secretary, Principal Executive Officer Preston Klassen Was Terminated From Positions, Effective Feb. 1
SHAREHOLDER ALERT: Weiss Law Reminds MTCR, OFIX, APEN, and TCFC Shareholders About Its Ongoing Investigations
NEW YORK, Dec. 30, 2022 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your righ
Metacrine, Equillium And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. (NASDAQ:EQ) mutual
Equillium, Metacrine Agree to Terminate Proposed Merger
03:48 AM EST, 12/27/2022 (MT Newswires) -- Equillium (EQ) and Metacrine (MTCR) said late Friday they have mutually agreed to terminate their proposed merger. Equillium aimed to purchase Metacrine in a
Metacrine Shares Rise 10% Following Scrapped Equillium Deal
By Denny Jacob Metacrine Inc. shares rose 10% to 48 cents in after-hours trading Friday after the company and Equillium Inc. mutually agreed to terminate their merger deal. The biotechnology company
Metacrine Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 14%
Metacrine Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 14%
Equillium, Metacrine Agree to Terminate Merger Deal
By Sabela Ojea Equillium Inc. said Friday that it terminated its merger deal with biotechnology company Metacrine Inc. by mutual agreement. The clinical-stage biotechnology company said it first app
Metacrine, Equillium Call off Merger
Metacrine Common Stock Shares To Resume Trade At 4:30 P.m. ET
Metacrine Common Stock Shares To Resume Trade At 4:30 p.m. ET
Metacrine Shares Halted, News Pending
Metacrine Shares Halted, News Pending
No Data